Patents by Inventor Ethan SYLVAIN

Ethan SYLVAIN has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • PEPTIDE COMPOSITIONS AND METHODS OF USE
    Publication number: 20230287052
    Abstract: Provided herein are compositions including peptides, pharmaceutical preparations thereof, and methods of preventing photoreceptor death therewith and protecting of retinal cells, including, but not limited to, photoreceptors and retinal pigment epithelium, from Fas-or TRAIL-mediated apoptosis.
    Type: Application
    Filed: January 24, 2023
    Publication date: September 14, 2023
    Inventors: Cagri G. BESIRLI, Alexander J. BRIDGES, John K. FRESHLEY, William A. HUNKE, Linda L. JOHNSON, Francis X. SMITH, Ethan SYLVAIN, David N. ZACKS
  • Peptide compositions and methods of use
    Patent number: 11597749
    Abstract: Provided herein are compositions including peptides, pharmaceutical preparations thereof, and methods of preventing photoreceptor death therewith and protecting of retinal cells, including, but not limited to, photoreceptors and retinal pigment epithelium, from Fas- or TRAIL-mediated apoptosis.
    Type: Grant
    Filed: October 6, 2020
    Date of Patent: March 7, 2023
    Assignees: THE REGENTS OF THE UNIVERSITY OF MICHIGAN, ONL THERAPEUTICS, INC.
    Inventors: Cagri G. Besirli, Alexander J. Bridges, John K. Freshley, William A. Hunke, Linda L. Johnson, Francis X. Smith, Ethan Sylvain, David N. Zacks
  • PEPTIDE COMPOSITIONS AND METHODS OF USE
    Publication number: 20210094985
    Abstract: Provided herein are compositions including peptides, pharmaceutical preparations thereof, and methods of preventing photoreceptor death therewith and protecting of retinal cells, including, but not limited to, photoreceptors and retinal pigment epithelium, from Fas- or TRAIL-mediated apoptosis.
    Type: Application
    Filed: October 6, 2020
    Publication date: April 1, 2021
    Inventors: Cagri G. BESIRLI, Alexander J. BRIDGES, John K. FRESHLEY, William A. HUNKE, Linda L. JOHNSON, Francis X. Smith, Ethan SYLVAIN, David N. ZACKS
  • Peptide compositions and methods of use
    Patent number: 10829518
    Abstract: Provided herein are compositions including peptides, pharmaceutical preparations thereof, and methods of preventing photoreceptor death therewith and protecting of retinal cells, including, but not limited to, photoreceptors and retinal pigment epithelium, from Fas- or TRAIL-mediated apoptosis.
    Type: Grant
    Filed: November 4, 2019
    Date of Patent: November 10, 2020
    Assignees: ONL THERAPEUTICS. INC., THE REGENT OF THE UNIVERSITY OF MICHIGAN
    Inventors: Cagri G. Besirli, Alexander J. Bridges, John K. Freshley, William A. Hunke, Linda L. Johnson, Francis X. Smith, Ethan Sylvain, David N. Zacks
  • PEPTIDE COMPOSITIONS AND METHODS OF USE
    Publication number: 20200123201
    Abstract: Provided herein are compositions including peptides, pharmaceutical preparations thereof, and methods of preventing photoreceptor death therewith and protecting of retinal cells, including, but not limited to, photoreceptors and retinal pigment epithelium, from Fas- or TRAIL-mediated apoptosis.
    Type: Application
    Filed: November 4, 2019
    Publication date: April 23, 2020
    Applicants: ONL Therapeutics, Inc., The Regents of the University of Michigan
    Inventors: Cagri G. BESIRLI, Alexander J. BRIDGES, John K. FRESHLEY, William A. HUNKE, Linda L. JOHNSON, Francis X. SMITH, Ethan SYLVAIN, David N. ZACKS
  • Peptide compositions and methods of use
    Patent number: 10508134
    Abstract: Provided herein are compositions including peptides, pharmaceutical preparations thereof, and methods of preventing photoreceptor death therewith and protecting of retinal cells, including, but not limited to, photoreceptors and retinal pigment epithelium, from Fas- or TRAIL-mediated apoptosis.
    Type: Grant
    Filed: April 29, 2016
    Date of Patent: December 17, 2019
    Assignees: ONL Therapeutics, Inc., The Regents Of The University of Michigan
    Inventors: Cagri G. Besirli, Alexander J. Bridges, John K. Freshley, William A. Hunke, Linda L. Johnson, Francis X. Smith, Ethan Sylvain, David N. Zacks
  • PEPTIDE COMPOSITIONS AND METHODS OF USE
    Publication number: 20180291062
    Abstract: Provided herein are compositions including peptides, pharmaceutical preparations thereof, and methods of preventing photoreceptor death therewith and protecting of retinal cells, including, but not limited to, photoreceptors and retinal pigment epithelium, from Fas- or TRAIL-mediated apoptosis.
    Type: Application
    Filed: April 29, 2016
    Publication date: October 11, 2018
    Applicants: ONL Therapeutics, Inc., The Regents of the University of Michigan
    Inventors: Cagri G. BESIRLI, Alexander J. BRIDGES, John K. FRESHLEY, William A. HUNKE, Linda L. JOHNSON, Francis X. SMITH, Ethan SYLVAIN, David N. ZACKS